Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2012
05/18/2012CA2815179A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012CA2814828A1 Method of treatment for mental disorders
05/17/2012US20120123115 Cyclic guanidine ionic liquid
05/17/2012US20120123114 Quinazoline derivatives having tyrosine kinase inhibitory activity
05/17/2012US20120122931 Indole derivative or pharmaceutically acceptable salt thereof
05/17/2012US20120122929 Heteroarylpiperidine and -piperazine derivatives as fungicides
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122886 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
05/17/2012US20120122863 Quinazolinedione Chymase Inhibitors
05/17/2012US20120122862 Arginine derivatives with np-i antagonistic activity
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
05/17/2012US20120122854 Carbocyclic Fused Cyclic Amines
05/17/2012US20120122849 Pkm2 modulators for use in the treatment of cancer
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122820 Prodrugs and the use thereof
05/17/2012US20120122773 N-substituted-cyclic amino derivative
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121509 Vital fluorochrome conjugates and methods of use
05/16/2012EP2452937A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
05/16/2012EP2451808A1 Pyridazine compounds for controlling invertebrate pests
05/16/2012EP2451804A1 Pyridazine compounds for controlling invertebrate pests
05/16/2012EP2451794A2 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer
05/16/2012EP2451453A1 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP2268625B1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
05/16/2012EP2044028B1 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
05/16/2012EP1934233B1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
05/16/2012EP1852428B1 4-cyclopropyl-1,2,3-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
05/16/2012EP1836200B1 Benzisothiazole-1, 1-dioxide acting as antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof
05/16/2012CN1931827B 2- and 2,5-substituted phenylketo-enols
05/16/2012CN102459256A Solid forms of an azocyclic amide
05/16/2012CN102459255A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459254A Thiazolylpiperidine derivates as fungicides
05/16/2012CN102459251A 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 Compound bicyclic heteroaryl moiety having two fused leukotriene a4 hydrolase as modulators of
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102459248A 作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxepin-triene and their method of use and manufacture
05/16/2012CN102459236A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459232A 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
05/16/2012CN102459230A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459229A 用作食欲肽拮抗剂的3-氮杂二环[4.1.0]庚烷 Orexin antagonists used azabicyclo [4.1.0] heptane
05/16/2012CN102459228A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459227A Ccr2的4-氮杂环丁烷基-1-苯基-环己烷拮抗剂 Ccr2 4-azetidinyl-1-phenyl - cyclohexane antagonist
05/16/2012CN102459226A Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroatom attached - cyclohexane antagonist
05/16/2012CN102459225A Ccr2的4-氮杂环丁烷基-1-杂芳基-环己烷拮抗剂 Ccr2 4-azetidinyl -1- heteroaryl - cyclohexane antagonist
05/16/2012CN102459223A 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
05/16/2012CN102459215A 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
05/16/2012CN102459207A 环戊二烯并[c]吡咯-2-甲酸酯衍生物、其制备及其治疗用途 Cyclopenta [c] pyrrole-2-carboxylic acid ester derivatives, their preparation and their therapeutic use
05/16/2012CN102459203A 用于调控视磺醇与视黄醇结合蛋白4(rbp4)结合的组合物和方法 Depending on the regulation of sulfur alcohol and retinol-binding protein 4 (rbp4) combination compositions and methods for
05/16/2012CN102459183A Inhibitors of human immunodeficiency virus replication
05/16/2012CN102459175A 用于治疗糖尿病的哌啶衍生物 For treating diabetes piperidine derivative
05/16/2012CN102459167A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459166A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459165A 抗病毒化合物 Antiviral compounds
05/16/2012CN102458402A Nicotinamide compounds useful as kinase modulators
05/16/2012CN102458394A Treatment or prophylaxis of proliferative conditions
05/16/2012CN102453028A Antifungal agent 2-[(2,3-dihydro-4H-benzo-[b]thiapyran-4-ylidene) hydrazono]-4-oxotetrahydro thiazole (oxazole)-5-acetic acid derivative
05/15/2012US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/15/2012US8178688 Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
05/15/2012US8178674 Process for the preparation of ziprasidone
05/15/2012US8178671 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
05/15/2012US8178668 2-aminopyridine kinase inhibitors
05/15/2012US8178579 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
05/15/2012US8178560 Therapeutic agents useful for treating pain
05/15/2012US8178559 Organic compounds
05/15/2012US8178557 Compounds and methods of use
05/15/2012US8178522 Thiazoles
05/15/2012CA2694480C Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
05/15/2012CA2670703C Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/15/2012CA2578023C Processes for the preparation of isothiazole derivatives
05/15/2012CA2576065C Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
05/15/2012CA2526361C Amide derivative
05/15/2012CA2517361C Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/15/2012CA2463569C Activator for peroxisome proliferator-activated receptor .delta.
05/15/2012CA2430978C Vla-4 inhibitors
05/15/2012CA2378243C Methods for treating or preventing pain and anxiety
05/10/2012WO2012061428A2 Nicotinamides as jak kinase modulators
05/10/2012WO2012061415A1 Oxypyrimidines as syk modulators
05/10/2012WO2012061290A2 Pesticidal compositions and processes related thereto
05/10/2012WO2012059932A1 2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
05/10/2012WO2012059497A1 N-hetarylmethyl pyrazolylcarboxamides
05/10/2012WO2012059442A2 Neurotrypsin inhibitors
05/10/2012WO2012021707A3 Premature-termination-codons readthrough compounds
05/10/2012US20120116072 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115882 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
05/10/2012US20120115879 Method of treatment for mental disorders
05/10/2012US20120115876 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
05/10/2012US20120115870 Control of intraocular pressure using alk5 modulation agents
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115868 Novel triazole compounds ii
05/10/2012US20120115856 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
05/10/2012US20120115855 Inhibitors of hcv ns5a
05/10/2012US20120115845 Therapeutic agents
05/10/2012US20120115844 Novel triazole compounds i
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115811 Phenylanaline amide derivatives useful for treating insulin-related diseases and conditions
05/10/2012US20120114765 Anti-neoplastic compounds, compositions and methods
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 628